Home » Topics » Conferences

Conferences
RSS

N-Alkylated saccharins from Merck & Co. with potential in BPH therapy

April 2, 1998

Research at Pfizer leads to potent CysLT1 antagonist

April 2, 1998

Merck & Co. identifies orally active, short-acting GH secretatogue

April 2, 1998

Liposomal telomerase antisense oligonucleotide effective alone and in combination

April 2, 1998

Protein farnesyltransferase inhibitor advanced to clinical trials by Schering-Plough

April 2, 1998

Preclinical data indicates efficacy of AltaRex's approach to cancer immunotherapy

April 2, 1998

Cardioprotective effects of new Lederle compound assessed

April 2, 1998

Dramatic anticancer activity observed with FGN-1 in animal models

April 2, 1998

Nefiracetam: a potential treatment for PCP addiction?

April 2, 1998

TAPET efficacy reported at AACR meeting

April 2, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 19, 2025.
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 19, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
Rare earth: Biomarin to use global reach post-$4.8B Amicus buy
BioWorld
Biomarin Pharmaceutical Inc. followed up its May takeover of Inozyme Pharma Inc. with a much larger agreement to acquire Amicus Therapeutics Inc. for $14.50 per...